Baseline disease characteristics. The mutational and cytogenetic profile of patients enrolled in this study are shown in the heat map. Previous lines of Rx are divided into salvage number for AML and total number of previous lines, including number of lines of Rx for any antecedent hematologic neoplasm. Of the 24 patients enrolled, 22 had AML and 2 had MDS. Other Int, other intermediate nondiploid karyotypic abnormalities; Rx: treatment.